Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Health-related quality of life and disease-modifying treatment behaviour in relapsing-remitting multiple sclerosis - a multicentre cohort study.
Evaluation of serum oxidant/antioxidant balance in multiple sclerosis.
Neuropsychological Aspects of Childhood Multiple Sclerosis: An Overview.
Association of human endogenous retroviruses with multiple sclerosis and possible interactions with herpes viruses.
Bag3-Induced Autophagy Is Associated with Degradation of JCV Oncoprotein, T-Ag.
Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis.
Olfactory dysfunction in multiple sclerosis.
Leflunomide and teriflunomide: altering the metabolism of pyrimidines for the treatment of autoimmune diseases.
Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells.
Anti-JC virus seroprevalence in a Finnish MS cohort.
Conference Report: Multiple Sclerosis Update: Hot topics from 5th Joint Triennial Congress of the European and Americas Committees for Treatment and Research in Multiple Sclerosis (ECTRIMS/ACTRIMS).
Spinal Cord Atrophy and Early Motor Recovery following Transverse Myelitis in Pediatric Patients.
[Unified assessment of adverse events of multiple sclerosis disease modifying drugs.]
Can we safely target the WNT pathway?
Accelerated repair of demyelinated CNS lesions in the absence of non-muscle myosin IIB.
Riluzole enhances glutamate uptake in rat astrocyte cultures.
High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis.
In Active Relapsing-Remitting Multiple Sclerosis, Effector T Cell Resistance to Adaptive Tregs Involves IL-6-Mediated Signaling.
Treatment of HIV and Risk of Multiple Sclerosis.
Discovery of Biologically Active Oncologic and Immunologic Small Molecule Therapies using Zebrafish: Overview and Example of Modulation of T Cell Activation.
Do not treat from CIS onset: evaluate disease course and prognosis first - No (treat!).
SIGLEC1 and SIGLEC7 expression in circulating monocytes of patients with multiple sclerosis.
Self-Reported Fatigue and Energy Cost During Walking Are Not Related in Patients With Multiple Sclerosis.
Evaluation of a new approach for semi-automatic segmentation of the cerebellum in patients with multiple sclerosis.
Optic Neuritis Probably Induced by Isotretinoin.

Pages